News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Peter Pisters: Thrilled to celebrate the 10-year anniversary of MD Anderson’s Patient and Family Advisor Program
Photo from Peter Pisters/LinkedIn
May 26, 2024, 10:49

Peter Pisters: Thrilled to celebrate the 10-year anniversary of MD Anderson’s Patient and Family Advisor Program

Peter Pisters, President at MD Anderson Cancer Center, shared on LinkedIn:

“Thrilled to celebrate the 10-year anniversary of MD Anderson Cancer Center’s Patient and Family Advisor Program. .

We are fortunate to have such an incredible community dedicated to creating impact by enhancing the patient and family experience at our organization.”

Peter Pisters

Source: Peter Pisters/LinkedIn

cancer MD Anderson Cancer Center OncoDaily Oncology Patient and Family Advisor Program. Peter Pisters
Special Coverage
Blog
Apr 5, 2025, 02:56
Did you know ALK Positive can help you gain access to world-leading specialists - at no charge?
Blog
Apr 4, 2025, 20:41
Michael Sapienza: Colorectal Cancer Alliance is hiring a VP of Data Intelligence and Technology
Science
Apr 4, 2025, 20:29
Gaëlle Saint-Hilary: Benefit-risk assessment of ivosidenib vs. placebo in mIDH1 cholangiocarcinoma
Blog
Apr 4, 2025, 20:12
David Planchard: A pleasure to discuss diagnostic and therapeutic advances in EGFR lung patients in Cannes
Science
Apr 4, 2025, 19:52
Paolo Bossi: Immunotherapy plus cetuximab in advanced/metastatic cutaneous squamous cell carcinoma
Blog
Apr 4, 2025, 19:34
Matthew Kurian: The barriers to AI adoption in oncology
Blog
Apr 4, 2025, 19:19
Michaela Cada: Proud to be part of the SickKids family for 20 years
Blog
Apr 4, 2025, 19:05
Laurence Albiges: Day 1 of ESMO Preceptorship in metastatic urothelial RCC cancer
Blog
Apr 4, 2025, 18:55
The invisible killer in your lungs - Pink Hearts Cancer Support Foundation
Blog
Apr 4, 2025, 18:54
Yelak Biru: How pharma medical affairs and innovation teams can learn from Myelo’s AI journey
Insight
Apr 4, 2025, 18:36
Luis Lara-Mejía: Neoadjuvant aumolertinib converted 45.1% of unresectable stage III EGFRm NSCLC to resectable status
Insight
Apr 4, 2025, 18:06
Hypofractionated Radiotherapy for Soft Tissue Sarcomas